Skin Cancer Diagnostics & Therapeutics Market Report: Trends, Forecast and Competitive Analysis to 2030

October 2023 | 150 pages | ID: S88660BC6C1CEN
Lucintel

Abstracts

Lucintel has been in the business of market research and management consulting since 2000 and has published over 1000 market intelligence reports in various markets / applications and served over 1,000 clients worldwide. This study is a culmination of four months of full-time effort performed by Lucintel's analyst team. The analysts used the following sources for the creation and completion of this valuable report:
In-depth interviews of the major players in this market
Detailed secondary research from competitors’ financial statements and published data
Extensive searches of published works, market, and database information pertaining to industry news, company press releases, and customer intentions
A compilation of the experiences, judgments, and insights of Lucintel’s professionals, who have analyzed and tracked this market over the years.
Extensive research and interviews are conducted across the supply chain of this market to estimate market share, market size, trends, drivers, challenges, and forecasts. Below is a brief summary of the primary interviews that were conducted by job function for this report.

Thus, Lucintel compiles vast amounts of data from numerous sources, validates the integrity of that data, and performs a comprehensive analysis. Lucintel then organizes the data, its findings, and insights into a concise report designed to support the strategic decision-making process. The figure below is a graphical representation of Lucintel’s research process.

Contents

1. EXECUTIVE SUMMARY


2. GLOBAL SKIN CANCER DIAGNOSTICS & THERAPEUTICS MARKET : MARKET DYNAMICS

2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges

3. MARKET TRENDS AND FORECAST ANALYSIS FROM 2018 TO 2030

3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
3.2. Global Skin Cancer Diagnostics & Therapeutics Market Trends (2018-2023) and Forecast (2024-2030)
3.3: Global Skin Cancer Diagnostics & Therapeutics Market by Cancer Type
  3.3.1: Melanoma
  3.3.2: Non-melanoma
3.4: Global Skin Cancer Diagnostics & Therapeutics Market by Type
  3.4.1: Diagnosis
  3.4.2: Therapeutics
  3.4.3: Others

4. MARKET TRENDS AND FORECAST ANALYSIS BY REGION FROM 2018 TO 2030

4.1: Global Skin Cancer Diagnostics & Therapeutics Market by Region
4.2: North American Skin Cancer Diagnostics & Therapeutics Market
  4.2.2: North American Skin Cancer Diagnostics & Therapeutics Market by Type: Diagnosis, Therapeutics, and Others
4.3: European Skin Cancer Diagnostics & Therapeutics Market
  4.3.1: European Skin Cancer Diagnostics & Therapeutics Market by Cancer Type: Melanoma and Non-melanoma
  4.3.2: European Skin Cancer Diagnostics & Therapeutics Market by Type: Diagnosis, Therapeutics, and Others
4.4: APAC Skin Cancer Diagnostics & Therapeutics Market
  4.4.1: APAC Skin Cancer Diagnostics & Therapeutics Market by Cancer Type: Melanoma and Non-melanoma
  4.4.2: APAC Skin Cancer Diagnostics & Therapeutics Market by Type: Diagnosis, Therapeutics, and Others
4.5: ROW Skin Cancer Diagnostics & Therapeutics Market
  4.5.1: ROW Skin Cancer Diagnostics & Therapeutics Market by Cancer Type: Melanoma and Non-melanoma
  4.5.2: ROW Skin Cancer Diagnostics & Therapeutics Market by Type: Diagnosis, Therapeutics, and Others

5. COMPETITOR ANALYSIS

5.1: Product Portfolio Analysis
5.2: Operational Integration
5.3: Porter’s Five Forces Analysis

6. GROWTH OPPORTUNITIES AND STRATEGIC ANALYSIS

6.1: Growth Opportunity Analysis
  6.1.1: Growth Opportunities for the Global Skin Cancer Diagnostics & Therapeutics Market by Cancer Type
  6.1.2: Growth Opportunities for the Global Skin Cancer Diagnostics & Therapeutics Market by Type
  6.1.3: Growth Opportunities for the Global Skin Cancer Diagnostics & Therapeutics Market by Region
6.2: Emerging Trends in the Global Skin Cancer Diagnostics & Therapeutics Market
6.3: Strategic Analysis
  6.3.1: New Product Development
  6.3.2: Capacity Expansion of the Global Skin Cancer Diagnostics & Therapeutics Market
  6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Skin Cancer Diagnostics & Therapeutics Market
  6.3.4: Certification and Licensing

7. COMPANY PROFILES OF LEADING PLAYERS

7.1: AB Science
7.2: Abbott Laboratories
7.3: Amgen
7.4: AstraZeneca
7.5: Bristol-Myers Squibb
7.6: Castle Biosciences
7.7: Daiichi Sankyo
7.8: DAMAE Medical
7.9: DermTech
7.10: F. Hoffmann-La Roche